Multiple myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

4, 2024 — A new study shows strong alignment between real-world outcomes and those seen in clinical trials among a broad population of patients with relapsed or refractory multiple myeloma.

Multiple myeloma is a kind of blood cancer that starts in white blood cells called plasma cells. Cancerous plasma cells grow out of control in your bone marrow, so there’s not enough room for ...

After a while, the color of the population whose genetic ... of different cell populations is especially important in ...

Braunstein, MD, PhD, FACP, and hematology/oncology fellow Olivia Main, MD, talk about their choices for a patient with ...

Historically, we evaluated myeloma through monoclonal proteins or free light chains in the blood and urine and percentage of plasma cells in the bone marrow. But this is like the iceberg ...

Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...

Hamlet Gasoyan, MD, discussed the implications of a multiple myeloma study’s findings and their potential impact on clinical ...

GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects multi-blockbuster ...

Your physician will also find out the stage of your cancer. To stage multiple myeloma, we need to see how far along your disease is. Your physician will use blood tests and a bone marrow biopsy to ...